A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier
Clinical and Molecular Hepatology
;
: 225-228, 2012.
Artículo
en Inglés
| WPRIM
| ID: wpr-101274
ABSTRACT
Hepatitis B virus (HBV) may be reactivated after chemotherapy or immunosuppressive therapy, and therefore administration of antiviral agents before such treatment is recommended. Most reported cases of reactivation are associated with high doses of immunosuppressive agents or combination therapy. We present a case of a previously inactive HBV carrier with an acute severe flare-up during a long-term, very-low-dose (2.5 mg/day) steroid treatment for rheumatoid arthritis. We suggest that even a minimal dose of single-regimen oral steroid can cause reactivation of indolent, inactive HBV.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Antivirales
/
Artritis Reumatoide
/
Esteroides
/
Activación Viral
/
ADN Viral
/
Tomografía Computarizada por Rayos X
/
Virus de la Hepatitis B
/
Resultado del Tratamiento
/
Hepatitis B
/
Antígenos de Superficie de la Hepatitis B
Límite:
Anciano
/
Aged80
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Clinical and Molecular Hepatology
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS